An engineered TGF-β monomer that functions as a dominant negative to block TGF-β signaling

From National Research Council Canada

Download
  1. (PDF, 3 MB)
DOIResolve DOI: https://doi.org/10.1074/jbc.M116.768754
AuthorSearch for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for: 1; Search for: ; Search for: ; Search for: ; Search for: ; Search for:
Name affiliation
  1. National Research Council of Canada. Human Health Therapeutics
FormatText, Article
Abstract
Publication date
PublisherAmerican Society for Biochemistry and Molecular Biology
In
LanguageEnglish
Peer reviewedYes
NPARC number23002201
Export citationExport as RIS
Report a correctionReport a correction
Record identifier7fa45627-206c-465e-8616-06acc30fe7e8
Record created2017-09-05
Record modified2020-05-30
Date modified: